Gender Differences in the Inflammatory Response and Survival Following Haemorrhage and Subsequent Sepsis
Overview
Biology
Affiliations
Studies have shown gender dimorphism in cell-mediated immune responses following haemorrhage, with depressed responses in young males and maintained or enhanced responses in proestrus females. However, it remains unknown whether or not the sexually dimorphic immune response to haemorrhage provides any protection against a subsequent in vivo polymicrobial septic challenge. To study this, male and proestrus female C3H/HeN mice were subjected to haemorrhage (35+/-5 mmHg for 90 min followed by fluid resuscitation) or sham operation. Twenty-four hours thereafter, all mice were subjected to polymicrobial sepsis by cecal ligation and puncture (CLP) and survival was assessed over a 10 day period. Haemorrhage prior to CLP significantly increased mortality in males as compared to shams. In contrast, mortality in females following CLP was comparable between the sham and haemorrhage groups. Plasma levels of interleukin (IL-)6, tumour necrosis factor (TNF)-alpha and prostaglandin E(2)(PGE(2)) at 5 h after CLP were significantly increased in males subjected to prior haemorrhage. In contrast, plasma levels of IL-6 and TNF-alpha in females did not increase under such conditions. PGE(2)levels were comparable in males and females following CLP, however prior haemorrhage significantly reduced PGE(2)levels in females, whereas no change was observed in males. Liver and splenic expression of cyclooxygenase-2 protein paralleled the changes in plasma PGE(2). Female sex hormones, therefore, appear to play an important role not only in maintaining immune function following haemorrhage, but also provide a survival advantage against subsequent septic challenge.
Sex or gender differences in treatment outcomes of sepsis and septic shock.
Min S, Yong H, Kim D Acute Crit Care. 2024; 39(2):207-213.
PMID: 38863351 PMC: 11167424. DOI: 10.4266/acc.2024.00591.
Sex-related immunity: could Toll-like receptors be the answer in acute inflammatory response?.
Popotas A, Casimir G, Corazza F, Lefevre N Front Immunol. 2024; 15:1379754.
PMID: 38835761 PMC: 11148260. DOI: 10.3389/fimmu.2024.1379754.
Disruption of TIGAR-TAK1 alleviates immunopathology in a murine model of sepsis.
Wang D, Li Y, Yang H, Shen X, Shi X, Li C Nat Commun. 2024; 15(1):4340.
PMID: 38773142 PMC: 11109194. DOI: 10.1038/s41467-024-48708-0.
Ham S, Abraham M, Deutschman C, Taylor M Front Immunol. 2024; 15:1366955.
PMID: 38562928 PMC: 10982361. DOI: 10.3389/fimmu.2024.1366955.
Jiang W, Song L, Zhang Y, Ba J, Yuan J, Li X Eur J Med Res. 2024; 29(1):56.
PMID: 38229118 PMC: 10792932. DOI: 10.1186/s40001-024-01651-8.